[LGND] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
04-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -79.41%
YoY- -88.23%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Revenue 14,602 15,958 11,651 5,636 3,896 5,958 9,470 7.48%
PBT -74 2,150 1,370 -522 -4,292 -2,715 -7,482 -53.65%
Tax 15 53 66 -35 -13,778 274 -2,366 -
NP 754 2,097 1,495 1,133 9,625 -2,750 -5,116 -
Tax Rate - -2.47% -4.82% - - - - -
Total Cost 13,848 13,861 10,156 4,503 -5,729 8,708 14,586 -0.86%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
NP Margin 5.16 13.14 12.83 20.10 247.05 -46.16 -54.02 -
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
EPS 0.04 0.10 0.07 0.07 0.49 -0.14 -0.27 -
EPS Diluted 0.04 0.10 0.07 0.07 0.49 -0.14 -0.27 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.